Research Analysts Offer Predictions for KPTI Q1 Earnings
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Free Report) – Research analysts at HC Wainwright raised their Q1 2025 earnings per share estimates for Karyopharm Therapeutics in a research report issued on Thursday, February 20th. HC Wainwright analyst E. White now anticipates that the company will post earnings of ($0.29) per share for the quarter, up from […]
